Vaping study reveals how young adults react to new nicotine substitute
NCT ID NCT06868368
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study looked at how 53 young adults (ages 21-34) who regularly vape perceive and react to e-cigarettes containing a new substance called metatine (6-methyl nicotine). Researchers measured how the body processes metatine, puffing behavior, sensory experiences, and appeal ratings. The goal was to understand the effects and potential abuse liability of these products.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABUSE TOBACCO are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital therapy aims to help teens with chronic pain face their fears
- 5-Day product swap may cut harmful chemicals in body
- Cooling agents in vapes: do they make them more addictive?
- 15,000 firefighters to reveal hidden job health risks
- Your blood, urine, and dust could help scientists make better tests